ABDULLAH ARSHAD: Open Payments
NPI 1477660637 · HAYTI, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,796 in 52 payments from 15 companies in 2025. Trend: 2023 $1,646 · 2024 $990 · 2025 $1,796
Food & beverage: $928Travel & lodging: $754Education: $114
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 1 | $754 |
| Alkermes, Inc. | 16 | $322 |
| Otsuka America Pharmaceutical, Inc. | 5 | $119 |
| Lundbeck LLC | 5 | $116 |
| E.R. Squibb & Sons, L.L.C. | 4 | $85 |
| Dexcom, Inc. | 4 | $75 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $75 |
| Sumitomo Pharma America, Inc. | 3 | $59 |
| Amgen Inc. | 2 | $34 |
| Vanda Pharmaceuticals Inc. | 2 | $32 |
Products named: SPRAVATO, ARISTADA, REXULTI, COBENFY, Dexcom G6 Transmitter, JARDIANCE, GEMTESA, OTEZLA.
Industry payments across MO — which companies pay providers there.
